Corbus is a biotechnology company that develops and commercializes novel therapeutics for the treatments of inflammatory and fibrotic diseases. Read more
Corbus Pharmaceuticals's Competitors, Revenue, Number of Employees, Funding and Acquisitions
52 Followers on Owler
Co-Founder & CEO
Yuval Cohen
Annual Revenue
Employees
Headquarters
TOP COMPETITORS OR ALTERNATIVES
Missing a competitor? Contribute!
EHP is seen as one of Corbus Pharmaceuticals's biggest rivals. EHP was founded in 2017 in San Diego, California. EHP operates in the Health Care Supplies industry. EHP generates $ less revenue than Corbus Pharmaceuticals.
Weigh-in!
Help the Owler community know moreExplore companies in similar locations and sectors
Trending News for Corbus Pharmaceuticals and Corbus Pharmaceuticals's Competitors
August 6, 2020
NewsOk
Corbus Pharmaceuticals: 2Q Earnings Snapshot
NORWOOD, Mass. (AP) _ Corbus Pharmaceuticals Holdings Inc.Read more on NewsOK.com... See more »
August 6, 2020
FinanzNachrichten
Galapagos NV: Galapagos reports solid H1 2020 progress
First half-year 2020 financial results: Group revenues and other income of €224.6 millionOperating lo... See more »
August 7, 2020
BioSpace
Crinetics Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Paltusotine received Orphan Drug Designation for the treatment of acromegaly Half of the enrolled pat... See more »
Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$36M
Corbus Pharmaceuticals's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 152M. Over the last four quarters, Corbus Pharmaceuticals's revenue has decreased by 88.9%. Specifically, in Q2 2020's revenue was $ < 1M; in Q1 2020, it was $1.8M; in Q4 2019, it was $2.5M; in Q3 2019, Corbus Pharmaceuticals's revenue was $2.6M.
Acquisitions
No recent acquisitions found related to Corbus Pharmaceuticals
Corbus Pharmaceuticals Funding History
Since Corbus Pharmaceuticals was founded in 2009, it has participated in 6 rounds of funding. In total Corbus Pharmaceuticals has raised $93.9M. Corbus Pharmaceuticals' last funding round was on Jul 2020 for a total of $50.0M
ROUND
FUNDING DATE
AMOUNT
INVESTORS
Debt
Jul 2020
$50M
K2 HealthVentures
Private Placement
Feb 2017
$27.2M
-
Equity
Jun 2014
$10.3M
-
Equity
Apr 2014
$6.3M
-
Equity
Mar 2014
$19.8K
-
Total Funding: $93.9M
Since Corbus Pharmaceuticals was founded in 2009, it has participated in 6 rounds of funding. In total Corbus Pharmaceuticals has raised $93.9M. Corbus Pharmaceuticals' last funding round was on Jul 2020 for a total of $50.0M
Investments
No recent investments found related to Corbus Pharmaceuticals
Corbus Pharmaceuticals News
August 5, 2020MarketScreener
Corbus Pharmaceuticals Completes Enrollment in DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
(marketscreener.com) 12-month, double-blind, placebo-controlled, multi-national study enrolled 176 pa... See more »
July 17, 2020STAT News
Corbus Pharma is nearing the readout of a pivotal drug study. Here's what you need to know
Corbus Pharmaceuticals is expected to announce top-line data by the end of the summer on its lead dru... See more »
July 8, 2020Boston Citybizlist
Corbus Pharmaceuticals Appoints George Golumbeski, Ph.D., to Board of Directors
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical-stage drug development company pione... See more »
June 29, 2020MarketScreener
Corbus Pharmaceuticals Presents Data Demonstrating ACR CRISS Score Reflects Patient-Reported Outcomes at 6th Systemic Sclerosis World E-Congress
(marketscreener.com) Phase 2 systemic sclerosis analyses show ACR CRISS score correlates with improve... See more »
June 1, 2020MarketScreener
Corbus Pharmaceuticals Announces Publication of Phase 2b Cystic Fibrosis Study Patient Demographics and Baseline Disease Characteristics in the Journal of Cystic Fibrosis
(marketscreener.com) Phase 2b study of lenabasum for treatment of cystic fibrosis enriched for patien... See more »
Corbus Pharmaceuticals Press Releases
March 5, 2020StreetInsider
Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2019 Results on March 12, 2020
- Management to host conference call and webcast on Thursday, March 12 at 8:30 a.m. ET - Norwood, MA,... See more »
December 9, 2019GlobeNewswire
Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System
- Live video webcast on Friday, December 13, 2019 from 1:00 PM - 2:30 PM ET... See more »
November 18, 2019StreetInsider
Corbus Pharmaceuticals Completes Enrollment of Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis
May 29, 2019GlobalNewswire
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in June
Norwood, MA, May 29, 2019 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("... See more »
May 28, 2019GlobeNewswire
Corbus Pharmaceuticals Announces Presentation of Six Abstracts at EULAR 2019 Annual Meeting
Norwood, MA , May 28, 2019 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (... See more »
May 15, 2019GlobeNewswire
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in May
Norwood, MA, May 15, 2019 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("... See more »
May 9, 2019GlobalNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bridgepoint, Corbus, and NIO and Encourages Investors to Contact the Firm
NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class a... See more »
Corbus Pharmaceuticals Videos
May 6, 2020Corbus Pharmaceuticals Youtube Channel
"What is Dermatomyositis? Peg Explains & Shares Her Journey" on YOUTUBE
November 26, 2019Corbus Pharmaceuticals Youtube Channel
"Tricia and Tom Legere - Living with Scleroderma" on YOUTUBE
September 18, 2019Corbus Pharmaceuticals Youtube Channel
"Kathleen Hally, Associate Clinical Project Manager, Speaks on the Opportunities for Growth at Corbus" on YOUTUBE
September 4, 2019Corbus Pharmaceuticals Youtube Channel
"Hitesh Wadhwa, Associate Director Data Management, on Corbus' Focus on Employee Development" on YOUTUBE
August 29, 2019Corbus Pharmaceuticals Youtube Channel
"Christie Joyce, Clinical Trial Associate II, Speaks on Corbus' Learning Environment" on YOUTUBE
August 20, 2019Corbus Pharmaceuticals Youtube Channel
"Fannie Weaver, Clinical Research Associate II, Shares What She Loves About Working at Corbus" on YOUTUBE
August 9, 2019Corbus Pharmaceuticals Youtube Channel
"Kristos Moshos, Director Pharmaceutical Development & Manufacturing, on Corbus' Health Culture" on YOUTUBE
Social Statistics
Headquarters
Trending Companies
IN THE NEWS
Codemasters | Apple | Relief Therapeutics Holding | Flipkart | j2 Global | Mohawk | Scorpio Bulkers | Regeneron | Real Madrid | TJX | Mastercard | Ballard | Old St. Mary's Catholic Church | Epic Games | ASML | U.S. Bank | Kc Education | Seagate | Revlon | Forum | Nike | HSBC | DARCARS | Intel | ON Semiconductor | CVS Health | Dexcom | Abbott | Marston's | Entegris | Pfizer | Alleghany | Jingdong | Global Partners | Tetra Insight | ryalto | Falcon Oil & Gas | Edwards | Illumina | ProAssurance | Android | Aflac | Salesforce | Equinix | Detroit Economic Growth | Lasea | Goodyear | Brum Costa | HCI Group | Masonite
PEOPLE ALSO VIEWED
Petranchkc | Insignia Venture Partners | Zippydogs | Rausch Coleman Homes Web Design And | Cvr Creative | YOOLTECH | Casco Electronics | Advantage Church Chairs | Simply Bovine | Angiotech Pharmaceuticals | Therapist Development Center | Harris global | Kimball Electronics | Ace Awning Company | The Mason Bar | Clinicalcurbside | Cody Sosebee Rodeo Clown/rock Star Fan Page | Dat Optic | Fourth District PTA | Climayre, Espacios Frescos | Kiplingesmeralda | Stinnett Family Farms | Delmonico | Vellvie International UG | The Sustainable Warehouse | 360 Infoworld | Canelineaustralia.com.au | Thayer, David M Cpa - Eadie & Payne | Rob Stefanski | sienadental.com
Summary
ABOUT
Overview
Corbus is a biotechnology company that develops and commercializes novel therapeutics for the treatments of inflammatory and fibrotic diseases. Corbus Pharmaceuticals was founded in 2009. Corbus Pharmaceuticals' headquarters is located in Norwood, Mas...
CEO
Corbus Pharmaceuticals's Co-Founder & CEO, Yuval Cohen, currently has an approval rating of 88%. Corbus Pharmaceuticals's primary competitors are EHP, Galapagos & Kadmon.Website
corbuspharma.comFrequently Asked Questions about Corbus Pharmaceuticals
When was Corbus Pharmaceuticals founded?
Corbus Pharmaceuticals was founded in 2009Who is Corbus Pharmaceuticals's CEO?
Corbus Pharmaceuticals's CEO is Yuval CohenHow much revenue does Corbus Pharmaceuticals generate?
Corbus Pharmaceuticals generates $36M in revenueHow much funding does Corbus Pharmaceuticals have?
Corbus Pharmaceuticals has historically raised $93.9M in funding
Where is Corbus Pharmaceuticals's headquarters?
Corbus Pharmaceuticals's headquarters is in Norwood Massachusetts, USAHow many employees does Corbus Pharmaceuticals have?
Corbus Pharmaceuticals has 77 employeesWhat sector does Corbus Pharmaceuticals operate in?
Corbus Pharmaceuticals is in Pharmaceuticals, BiotechnologyWho are Corbus Pharmaceuticals's competitors?
Corbus Pharmaceuticals's top competitors are EHP, Galapagos, Kadmon
